IOS Press Celebrates 30th Anniversary

April 7, 2017 - Amsterdam, The Netherlands, 7 April 2017 – IOS Press, publisher of scientific, technical and medical books and journals, celebrates its 30th anniversary this week. Friends and colleagues came together on the 4th of April for a mini-symposium in Amsterdam venue De Balie to commemorate this special event. The rest of the week was filled with social events and meetings with IOS Press’s collaborators. More...

April 7, 2017

3D Signatures’s TeloViewTM Software Identifies and Stages Patients with Alzheimer’s Disease from a Cheek Swab

March 30, 2017 - WINNIPEG, MB − 3D Signatures Inc. (TSXV:DXD; OTCQB:TDSGF; FSE:3D0) (the "Company" or "3DS"), is pleased to announce clinical study results which confirm that based on a swab from the inside of a patient’s cheek, its proprietary TeloViewTM software platform has the ability to identify patients with Alzheimer’s disease (“AD”) and, furthermore, distinguish between mild, moderate, and severe forms of the disease. The results of this confirmatory study have been accepted for publication in the peer-reviewed Journal of Alzheimer’s Disease. More...

March 30, 2017

Exercising 2.5 Hours Per Week Associated with Slower Declines in Parkinson’s Disease Patients

According to a new report published in the Journal of Parkinson’s Disease

March 24, 2017 - Amsterdam, NL – Parkinson’s disease (PD) is a progressive condition that often results in mobility impairments and can lead to decreased health-related quality of life (HRQL) and death. There is evidence that physical activity can delay decline in PD patients. In a study in the Journal of Parkinson’s Disease, researchers determined that that people who exercised regularly had significantly slower declines in HRQL and mobility over a two-year period. More...

March 24, 2017

Journal of Parkinson’s Disease Celebrates Key Breakthroughs that Shaped PD Research over the Last 200 Years

From the shaking palsy to alpha-synuclein, the stories behind the science from many of the researchers who played key roles in achieving significant milestones are published

March 22, 2017 - Amsterdam, The Netherlands - Marking the 200th anniversary of James Parkinson’s first published description of the disease that would come to bear his name, the Journal of Parkinson’s Disease is proud to publish Milestones in 200 Years of Parkinson’s Disease Research. This special issue features commentaries by luminaries in the field, who are responsible for some of the greatest advances in understanding and treating the disease since it was first characterized. The issue is openly available as a service to the Parkinson’s disease (PD) community. More...

March 22, 2017